申请人:Valeant Pharmaceuticals International
公开号:US08188314B2
公开(公告)日:2012-05-29
The present invention relates to benzyloxyanilide derivatives having the following structural formula:
The compounds of the present invention are useful for the treatment and prevention of diseases and disorders which are affected by activation or modulation of potassium ion channels. One such condition is seizure disorders.
本发明涉及以下结构式的苯甲氧基苯胺衍生物:本发明的化合物对于治疗和预防受钾离子通道的激活或调节影响的疾病和障碍非常有用。其中一种疾病是癫痫障碍。